Glenmede Trust CO Na Amphastar Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 24,743 shares of AMPH stock, worth $703,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,743

Previous 37,884 34.69%

Holding current value

$703,443

Previous $1.84 Million 50.05%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$36.84 - $53.4 $484,114 - $701,729	-13,141 Reduced 34.69%	24,743 $918,000
Q3 2024 Nov 13, 2024	BUY	$36.99 - $50.09 $830,018 - $1.12 Million	22,439 Added 145.28%	37,884 $1.84 Million
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $61,492 - $69,176	-1,591 Reduced 9.34%	15,445 $617,000
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $46,278 - $68,526	-1,080 Reduced 5.96%	17,036 $748,000
Q4 2023 Feb 13, 2024	BUY	$44.49 - $62.93 $341,327 - $482,798	7,672 Added 73.46%	18,116 $1.12 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $1,228 - $1,755	-27 Reduced 0.26%	10,444 $480,000
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $811 - $1,099	-29 Reduced 0.28%	10,471 $392,000
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $10,194 - $11,413	-365 Reduced 3.36%	10,500 $294,000
Q3 2022 Nov 16, 2022	BUY	$27.56 - $37.75 $8,764 - $12,004	318 Added 3.02%	10,865 $305,000
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $314,195 - $446,032	10,547 New	10,547 $366,000
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $1,847 - $2,208	-104 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.99 - $22.22 $1,763 - $2,177	-98 Reduced 48.51%	104 $1,000
Q2 2020 Aug 14, 2020	SELL	$14.25 - $22.46 $6,754 - $10,646	-474 Reduced 70.12%	202 $4,000
Q4 2019 Feb 12, 2020	BUY	$17.07 - $20.64 $2,236 - $2,703	131 Added 24.04%	676 $13,000
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $191 - $226	-10 Reduced 1.8%	545 $10,000
Q2 2019 Aug 13, 2019	SELL	$18.92 - $22.96 $794 - $964	-42 Reduced 7.04%	555 $11,000
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $6,343 - $8,058	358 Added 149.79%	597 $11,000
Q2 2018 Aug 15, 2018	BUY	$14.63 - $19.6 $3,496 - $4,684	239 New	239 $4,000

Others Institutions Holding AMPH

# of Institutions

273

Shares Held

35M

Call Options Held

26.5K

Put Options Held

7.9K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.39B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Amphastar Pharmaceuticals, Inc. Transaction History